-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Melanoma is a type of skin cancer characterized by the uncontrolled growth of pigment-producing cells located in the skin
Spanish researchers have recently discovered that the combination therapy of chemotherapy and BRAF inhibitors is a very effective strategy for the treatment of metastatic melanoma
Researchers from the Medical Institute of Del Mar Hospital and doctors from the Dermatology and Pathology Department of Del Mar Hospital participated in the study and analyzed the effect of the combination of two treatments on metastatic melanoma
The researchers tested the two individual therapies and combination therapies in mice and in vitro tumor cells
The co-corresponding author of the article, Dr.
This study also shows that low-dose chemotherapy (to avoid its toxicity), coupled with standard treatment with BRAF inhibitors, can have a huge impact on the progression of metastatic melanoma
The researchers also believe that this method can also be applied to other types of cancer, including some rare subtypes of melanoma, which are currently incurable due to the lack of BRAF gene mutations
Dr.
BRAF inhibitors are the gold standard method for the treatment of melanoma
# # #
Alonso-Marañón, J.